Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 23. Januar 2019
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1722  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 34435  
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
J Immunol Res
Pan RY, Chung WH, Chu MT, Chen SJ, Chen HC, Zheng L, Hung SI.
PMID: 30662919 [PubMed - in process]

Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome-Wide Association Study.
J Oncol
Yang C, Han C, Wang X, Liao X, Liu X, Qin W, Yu L, Zhu G, Su H, Lu S, Chen Z, Yu T, Liu Z, Huang K, Liu Z, Liang Y, Huang J, Peng T.
PMID: 30662464 [PubMed]

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
Front Pharmacol
Mo H, Jeter R, Bachmann A, Yount ST, Shen CL, Yeganehjoo H.
PMID: 30662405 [PubMed]

Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Eur J Surg Oncol
Yang M, Zhang Y, Zeng L, Ke NW, Tan CL, Tian BL, Xiang B, Liu XB.
PMID: 30661921 [PubMed - as supplied by publisher]

"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
Crit Rev Oncol Hematol
Lombardi P, Silvestri S, Marino D, Santarelli M, Campra D, De Paolis P, Aglietta M, Leone F, Rete Oncologica Piemonte e Valle d.
PMID: 30661653 [PubMed - in process]

Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study.
J Hepatol
Wang Q, Xia D, Bai W, Wang E, Sun J, Huang M, Mu W, Yin G, Li H, Zhao H, Li J, Zhang C, Zhu X, Wu J, Li J, Gong W, Li Z, Lin Z, Pan X, Shi H, Shao G, Liu J, Yang S, Zheng Y, Xu J, Song J, Wang W, Wang Z, Zhang Y, Ding R, Zhang H, Yu H, Zheng L, Gu W, You N, Wang G, Zhang S, Feng L, Liu L, Zhang P, Li X, Chen J, Xu T, Zhou W, Zeng H, Zhang Y, Huang W, Jiang W, Zhang W, Shao W, Li L, Niu J, Yuan J, Li X, Lv Y, Li K, Yin Z, Xia J, Fan D, Han G.
PMID: 30660709 [PubMed - as supplied by publisher]

Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery.
Ann Surg Oncol
Li HB, Zhao FQ, Zhou J.
PMID: 30659390 [PubMed - as supplied by publisher]

Overexpression of TBX3 transcription factor as a potential diagnostic marker for breast cancer.
Mol Clin Oncol
Aliwaini S, Lubbad AM, Shourfa A, Hamada HAA, Ayesh B, Abu Tayem HEM, Abu Mustafa A, Abu Rouk F, Redwan MM, Al-Najjar M.
PMID: 30655984 [PubMed]

Association between the insulin-like growth factor 1 gene rs2195239 and rs2162679 polymorphisms and cancer risk: a meta-analysis.
BMC Med Genet
Xu GP, Chen WX, Zhao Q, Zhou H, Chen SZ, Wu LF.
PMID: 30654740 [PubMed - in process]

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.
Eur J Cancer
Wang-Gillam A, Hubner RA, Siveke JT, Von Hoff DD, Belanger B, de Jong FA, Mirakhur B, Chen LT.
PMID: 30654298 [PubMed - as supplied by publisher]

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.
J Clin Oncol
Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.
PMID: 30653423 [PubMed - as supplied by publisher]

Prognostic value of PD-L1 expression in patients with pancreatic cancer: A PRISMA-compliant meta-analysis.
Medicine (Baltimore)
Hu Y, Chen W, Yan Z, Ma J, Zhu F, Huo J.
PMID: 30653106 [PubMed - in process]

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients.
Cancers (Basel)
van der Sijde F, Vietsch EE, Mustafa DAM, Besselink MG, Groot Koerkamp B, van Eijck CHJ.
PMID: 30650521 [PubMed]

Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study.
Langenbecks Arch Surg
Kurahara H, Shinchi H, Ohtsuka T, Miyasaka Y, Matsunaga T, Noshiro H, Adachi T, Eguchi S, Imamura N, Nanashima A, Sakamoto K, Nagano H, Ohta M, Inomata M, Chikamoto A, Baba H, Watanabe Y, Nishihara K, Yasunaga M, Okuda K, Natsugoe S, Nakamura M.
PMID: 30649607 [PubMed - as supplied by publisher]

Pancreatic cancer microenvironment: a current dilemma.
Clin Transl Med
Uzunparmak B, Sahin IH.
PMID: 30645701 [PubMed]

Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis.
Sci Rep
Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK.
PMID: 30644396 [PubMed - in process]

Elevated vitamin B12 levels and cancer risk in UK primary care: a THIN database cohort study.
Cancer Epidemiol Biomarkers Prev
Arendt JF, Sorensen HT, Horsfall LJ, Petersen I.
PMID: 30642843 [PubMed - as supplied by publisher]

Role of Oral Microbiota in Cancer Development.
PMID: 30642137 [PubMed]

Effect of Early Management on Pain and Depression in Patients with Pancreatobiliary Cancer: A Randomized Clinical Trial.
Cancers (Basel)
Woo SM, Song MK, Lee M, Joo J, Kim DH, Kim JH, Han SS, Park SJ, Kim TH, Lee WJ.
PMID: 30641928 [PubMed]

The signaling pathways that mediate the anti-cancer effects of calorie restriction.
Pharmacol Res
Lu Y, Tao F, Zhou MT, Tang KF.
PMID: 30641278 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 34435    Seite 1 von 1722  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1